Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a …

L de Jonge, J Worthington, F van Wifferen… - The lancet …, 2021 - thelancet.com
Background Colorectal cancer screening programmes worldwide have been disrupted
during the COVID-19 pandemic. We aimed to estimate the impact of hypothetical disruptions …

Calibration and validation of the colorectal cancer and adenoma incidence and mortality (CRC-AIM) microsimulation model using deep neural networks

V Vahdat, O Alagoz, JV Chen, L Saoud… - Medical Decision …, 2023 - journals.sagepub.com
Objectives Machine learning (ML)–based emulators improve the calibration of decision-
analytical models, but their performance in complex microsimulation models is yet to be …

Clinical validation of a multitarget fecal immunochemical test for colorectal cancer screening: a diagnostic test accuracy study

W de Klaver, PHA Wisse, F van Wifferen… - Annals of Internal …, 2021 - acpjournals.org
Background: The fecal immunochemical test (FIT) is used in colorectal cancer (CRC)
screening, yet it leaves room for improvement. Objective: To develop a multitarget FIT …

The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention …

PHA Wisse, W de Klaver, F van Wifferen… - The Lancet …, 2024 - thelancet.com
Background The faecal immunochemical test (FIT) is widely employed for colorectal cancer
screening. However, its sensitivity for advanced precursor lesions remains suboptimal. The …

Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A …

F van Wifferen, L de Jonge… - Journal of medical …, 2022 - journals.sagepub.com
Objectives Colorectal cancer (CRC) screening with a faecal immunochemical test (FIT) has
been disrupted in many countries during the COVID-19 pandemic. Performing catch-up of …

SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian …

JG McIntosh, JD Emery, A Wood, P Chondros… - Trials, 2023 - Springer
Background Australia persistently has one of the highest rates of colorectal cancer (CRC) in
the world. Australia's National Bowel Cancer Screening Program (NBCSP) sends a biennial …

[HTML][HTML] The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study

JB Lew, E Feletto, J Worthington, D Roder… - Journal of Cancer …, 2022 - Elsevier
Abstract Background Australian Aboriginal and Torres Strait Islander peoples experience
health and socioeconomic disparities, including lower life-expectancy, have a younger …

Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes

S Behar Harpaz, MF Weber, S Wade, PJ Ngo… - British Journal of …, 2023 - nature.com
Background A national, lung cancer screening programme is under consideration in
Australia, and we assessed cost-effectiveness using updated data and assumptions …

A progressive three-state model to estimate time to cancer: a likelihood-based approach

EU Akwiwu, T Klausch, HC Jodal, B Carvalho… - BMC medical research …, 2022 - Springer
Background To optimize colorectal cancer (CRC) screening and surveillance, information
regarding the time-dependent risk of advanced adenomas (AA) to develop into CRC is …

[HTML][HTML] Guidance for setting international standards on reporting longitudinal adherence to stool-based colorectal cancer screening

F van Wifferen, MJE Greuter, BI Lissenberg-Witte… - Preventive …, 2022 - Elsevier
Longitudinal adherence to colorectal cancer (CRC) screening is reported using different
summarizing measures, which hampers international comparison. We provide evidence to …